GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential

Type 2 diabetes mellitus (T2DM) is closely associated with cardiovascular diseases (CVD), including atherosclerosis, hypertension and heart failure. Some anti-diabetic medications are linked with an increased risk of weight gain or hypoglycemia which may reduce the efficacy of the intended anti-hype...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiaoxuan, Liu, Zhenghong, Ilyas, Iqra, Little, Peter J., Kamato, Danielle, Sahebka, Amirhossein, Chen, Zhengfang, Luo, Sihui, Zheng, Xueying, Weng, Jianping, Xu, Suowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193264/
https://www.ncbi.nlm.nih.gov/pubmed/34131405
http://dx.doi.org/10.7150/ijbs.59965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193264/
https://www.ncbi.nlm.nih.gov/pubmed/34131405
http://dx.doi.org/10.7150/ijbs.59965

Ejemplares similares